Security key
67080M103
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)
CUSIP: 67080M103
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 103,174,603
- Total 13F shares
- 117,027,314
- Share change
- +2,995,743
- Total reported value
- $1,813,892,353
- Put/Call ratio
- 5.8%
- Price per share
- $15.50
- Number of holders
- 194
- Value change
- +$39,578,803
- Number of buys
- 101
- Number of sells
- 69
Report period
Q1 2026
Institutions
194
Top holders
10
NRIX full security history
Previous quarter: Q4 2025
Nurix Therapeutics, Inc. SEC filings
Nurix Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080M103
Recent filing periods:
Top shareholders of NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.2%
from 13D/G
|
8,875,194
|
$168,362,430 | — | 31 Dec 2025 | |
| BAKER BROS. ADVISORS LP |
13D/G
13F
|
Company |
7.2%
|
7,527,996
|
$138,364,566 | $0 | 31 Dec 2025 | |
| Vestal Point Capital, LP |
13D/G
13F
|
Company |
6.3%
|
6,500,000
|
$100,815,000 | $0 | 31 Mar 2026 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
6.2%
from 13D/G
|
7,036,455
|
$133,481,551 | — | 31 Dec 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
5.4%
|
5,541,271
|
$85,945,115 | +$21,424,444 | 31 Mar 2026 | |
| Commodore Capital LP |
13F
13D/G
|
Company |
4.9%
from 13D/G
|
2,275,000
|
$43,156,750 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
4.2%
|
3,188,742
|
$36,861,858 | $0 | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
7.8%
|
8,093,908
|
$153,541,435 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
5,949,512
|
$112,862,243 | — | 31 Dec 2025 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
4.7%
|
4,897,159
|
$92,899,106 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
4.7%
|
4,881,069
|
$92,593,901 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
3,559,501
|
$67,523,734 | — | 31 Dec 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.4%
|
3,555,877
|
$67,454,987 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
3.4%
|
3,467,600
|
$65,780,372 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.1%
|
3,248,361
|
$61,622,000 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.1%
|
3,211,680
|
$60,925,570 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2.4%
|
2,486,792
|
$47,174,444 | — | 31 Dec 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
2.4%
|
2,473,885
|
$46,929,598 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,384,998
|
$45,250,415 | — | 31 Dec 2025 | |
| BRAIDWELL LP |
13F
|
Company |
2.1%
|
2,183,864
|
$41,427,900 | — | 31 Dec 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.9%
|
1,970,357
|
$37,377,672 | — | 31 Dec 2025 | |
| Trails Edge Capital Partners, LP |
13F
|
Company |
1.7%
|
1,743,220
|
$33,068,884 | — | 31 Dec 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
1.6%
|
1,602,539
|
$30,400,171 | — | 31 Dec 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,297,893
|
$24,621,030 | — | 31 Dec 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.3%
|
1,290,554
|
$24,481,809 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.3%
|
1,290,554
|
$24,481,809 | — | 31 Dec 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.2%
|
1,219,394
|
$23,131,904 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
1,152,930
|
$21,871,082 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
1,077,573
|
$20,441,559 | — | 31 Dec 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.94%
|
967,620
|
$18,355,751 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.94%
|
965,892
|
$18,322,971 | — | 31 Dec 2025 | |
| Longaeva Partners L.P. |
13F
|
Company |
0.9%
|
927,729
|
$17,599,019 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.9%
|
925,444
|
$17,555,673 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.78%
|
805,682
|
$15,283,787 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.76%
|
784,409
|
$14,880,238 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.71%
|
736,558
|
$13,972,505 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.71%
|
735,174
|
$13,946,251 | — | 31 Dec 2025 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.53%
|
547,000
|
$10,377,000 | — | 31 Dec 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.52%
|
537,500
|
$10,196,375 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.52%
|
534,259
|
$10,135,325 | — | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.48%
|
500,000
|
$9,485,000 | — | 31 Dec 2025 | |
| Elmind Capital, LP |
13F
|
Company |
0.45%
|
460,000
|
$8,726,200 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.42%
|
430,986
|
$8,176,070 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.41%
|
423,425
|
$8,032,373 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.33%
|
343,830
|
$6,522,455 | — | 31 Dec 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.31%
|
314,762
|
$5,971,035 | — | 31 Dec 2025 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.3%
|
306,003
|
$5,805,000 | — | 31 Dec 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.29%
|
300,000
|
$5,691,000 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
288,143
|
$5,466,070 | — | 31 Dec 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
261,204
|
$4,955,040 | — | 31 Dec 2025 |
Institutional Holders of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) as of Q1 2026
As of 31 Mar 2026,
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) was held by
194 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
117,027,314 shares.
The largest 10 holders included
BlackRock, Inc., Redmile Group, LLC, Vestal Point Capital, LP, Deep Track Capital, LP, FMR LLC, STATE STREET CORP, MORGAN STANLEY, BAKER BROS. ADVISORS LP, VANGUARD CAPITAL MANAGEMENT LLC, and GENERAL ATLANTIC, L.P..
This page lists
194
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
182
Q1 2026 holders
194
Holder diff
12
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.